IL6 and myeloid sarcoma: IL6 is also known (together with IL1β) to enhance T helper cell differentiation toward the TH17 subset, which is pathogenic in MS, but IL6 may also have homeostatic roles and it is endowed with regenerative or anti-inflammatory activities [46,47].